Protein that Makes Aggressive Mice Violent Found in Brain's Reward Area
D2-MSN (Labeled with eGFP, green), FosB (Red), and DAPI stained nuclei (Blue). Credit: Hossein Aleyasin, SfN
Aggressive behavior and the motivation to act aggressively have distinct molecular bases, according to a study of male mice published in JNeurosci. This finding suggests the possibility of reducing aggression by targeting a protein associated with addiction in a reward region of the brain.
Despite sharing core features with drug addiction, the mechanisms underlying aggression are far less understood. One shared mechanism may involve a transcription factor, ΔFosB, which builds up in the nucleus accumbens (NAc) in response to many different rewarding experiences, including sex and exercise.
Scott Russo, Elizabeth Heller, and colleagues found that higher levels of ΔFosB in NAc neurons were associated with more intense behaviors by aggressive mice defending their home cage from an intruder. Overexpressing ΔFosB in aggressive mice also increased their dominance over an opponent when they faced each other in a narrow tube. While increased ΔFosB in dopamine D1 receptor expressing medium spiny neurons (D1-MSNs) was associated with increased aggression intensity, mice with increased ΔFosB in D2-MSNs showed less preference for an environment where they previously encountered an intruder. These results identify distinct roles of ΔFosB in two different NAc cell types that regulate aggressive behavior and its rewarding qualities.
D2-MSNs (Labeled with eGFP, green), FosB stained nuclei (red), and DAPI stained nuclei. Separation of colors is an artifact caused by tilted coverslip. Credit: Hossein Aleyasin
This article has been republished from materials provided by Society for Neuroscience. Note: material may have been edited for length and content. For further information, please contact the cited source.
Aleyasin, H., Flanigan, M., Golden, S., Takahashi, A., Menard, C., & Pfau, M. et al. (2018). Cell-type-specific role of ΔFosB in nucleus accumbens in modulating inter-male aggression. The Journal Of Neuroscience, 0296-18. doi: 10.1523/jneurosci.0296-18.2018
The emerging technology of sonogenetics—a technique where cells are controlled by sound—offers the potential to one day replace pharmaceutical drugs or invasive surgical treatments for neurological conditions like epilepsy, Parkinson’s disease or post-traumatic stress disorder. A new research program could take this technique to the next level with $750,000 of funding.READ MORE
A team of researchers has discovered a combination of pharmaceutical drugs that not only increases healthy lifespan in the microscopic worm Caenorhabditis elegans (C. elegans), but also delays the rate of ageing in them, a finding that could someday mean longer, healthier lives for humans.READ MORE